Use of tamoxifen in a German shepherd dog with sclerosing encapsulating peritonitis

被引:18
作者
Etchepareborde, S. [1 ]
Heimann, M. [1 ]
Cohen-Solal, A. [1 ]
Hamaide, A. [1 ]
机构
[1] Univ Liege, Sch Vet Med, Dept Clin Sci, B-4000 Liege, Belgium
关键词
EARLY BREAST-CANCER; RETROPERITONEAL FIBROSIS; THERAPY;
D O I
10.1111/j.1748-5827.2010.00998.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
A German shepherd dog was diagnosed with sclerosing encapsulating peritonitis after an episode of peritonitis caused by a free intra-abdominal foreign body (stick). The foreign body had initially been treated by surgical removal and abdominal lavage. Postoperatively, peritoneal effusion persisted despite the use of methylprednisolone for 1 month and a second surgical exploration and abdominal lavage. After a third surgery at our institution (to breakdown abdominal adhesions) followed by open abdominal drainage, treatment with tamoxifen orally was initiated and within 2 weeks the dog's condition improved dramatically. Two months later, no fluid was present in the abdomen. The only apparent adverse reaction to tamoxifen therapy was swelling of the vulva. In humans, sclerosing encapsulating peritonitis is a known life-threatening complication following peritoneal dialysis. In veterinary medicine, most animals with sclerosing encapsulating peritonitis die because of chronic weight loss, peritoneal effusion and progression of concurrent disease. This dog's condition was unresponsive to methylprednisolone alone but was successfully treated with aggressive surgery including enterolysis and open abdominal lavage and the addition of tamoxifen.
引用
收藏
页码:649 / 653
页数:5
相关论文
共 25 条
[1]   Sclerosing encapsulating peritonitis in a dog with leishmaniasis [J].
Adamama-Moraitou, KK ;
Prassinos, NN ;
Patsikas, MN ;
Psychas, V ;
Tsioli, B ;
Rallis, TS .
JOURNAL OF SMALL ANIMAL PRACTICE, 2004, 45 (02) :117-121
[2]  
Allaria PM, 1999, J NEPHROL, V12, P395
[3]   New approaches to the understanding of tamoxifen action and resistance [J].
Berstein, LM ;
Zheng, H ;
Yue, W ;
Wang, JP ;
Lykkesfeldt, AE ;
Naftolin, F ;
Harada, N ;
Shanabrough, M ;
Santen, RJ .
ENDOCRINE-RELATED CANCER, 2003, 10 (02) :267-277
[4]  
BOOTHE HW, 1991, J AM VET MED ASSOC, V198, P267
[5]  
Cancarini GC, 2001, J NEPHROL, V14, pS39
[6]  
CLARK CP, 1991, SURGERY, V109, P502
[7]  
Fagugli RM, 1999, NEPHROL DIAL TRANSPL, V14, P1343
[8]   Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial [J].
Fisher, B ;
Dignam, J ;
Bryant, J ;
Wolmark, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :684-690
[9]  
FORNANDER T, 1989, LANCET, V1, P117
[10]  
Gupta S, 2007, CLIN NEPHROL, V68, P125